Alpha-1 Asthma Overlap Syndrome: a Clinical Overview

de Serres FJ, Blanco I, Fernandez-Bustillo E. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet. 2003;64:382–97.

PubMed  Article  Google Scholar 

Strnad P, McElvaney NG, Lomas DA. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382:1443–55.

CAS  PubMed  Article  Google Scholar 

Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in alpha1-antitrypsin deficiency. Eur Respir J [Internet]. 2017;50. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29191952.

Willis-Owen SAG, Cookson WOC, Moffatt MF. The genetics and genomics of asthma. Annu Rev Genomics Hum Genet. 2018;19:223–46.

CAS  PubMed  Article  Google Scholar 

Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11:404–6.

PubMed  Article  Google Scholar 

CDC. NHIS asthma data tables [Internet]. 2017. Available from: https://www.cdc.gov/asthma/nhis/default.htm.

McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ. Diagnosis and management of asthma in adults: a review. 2017;318:279–90.

Google Scholar 

Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–78.

CAS  PubMed  Article  Google Scholar 

Ortega VE, Li X, O’Neal WK, Lackey L, Ampleford E, Hawkins GA, et al. The effects of rare SERPINA1 variants on lung function and emphysema in SPIROMICS. Am J Respir Crit Care Med. 2020;201:540–54.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cummings EE, O’Reilly LP, King DE, Silverman RM, Miedel MT, Luke CJ, et al. Deficient and null variants of SERPINA1 are proteotoxic in a Caenorhabditis elegans model of alpha1-antitrypsin deficiency. PLoS ONE. 2015;10:e0141542.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360:2749–57.

Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev. 2011;242:10–30.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest. 1991;88:891–7.

King GG, James A, Harkness L, Wark PAB. Pathophysiology of severe asthma: we’ve only just started. Respirology. 2018;23:262–71.

PubMed  Article  Google Scholar 

Lemanske RF Jr. Inflammatory events in asthma: an expanding equation. J Allergy Clin Immunol. 2000;105:S633–6.

CAS  PubMed  Article  Google Scholar 

Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160:1001–8.

CAS  PubMed  Article  Google Scholar 

Sze E, Bhalla A, Nair P. Mechanisms and therapeutic strategies for non-T2 asthma. Allergy. 2020;75:311–25.

PubMed  Article  Google Scholar 

Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis. 1988;138:327–36.

CAS  PubMed  Article  Google Scholar 

Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax. 2004;59:441–5.

Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2007;176:1215–21.

PubMed  Article  Google Scholar 

Guest PJ, Hansell DM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol. 1992;45:260–6.

CAS  PubMed  Article  Google Scholar 

Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162:1277–84.

CAS  PubMed  Article  Google Scholar 

Cuvelier A, Muir JF, Hellot MF, Benhamou D, Martin JP, Bénichou J, et al. Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest. 2000;117:415–9.

CAS  PubMed  Article  Google Scholar 

Global Strategy for Asthma Management and Prevention, 2021 [Internet]. Global Initiative for Asthma; Available from: http://www.ginasthma.org.

Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789–815.

CAS  PubMed  Article  Google Scholar 

Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol. 2010;125:830–7.

PubMed  Article  Google Scholar 

Shah A, Panjabi C. Allergic aspergillosis of the respiratory tract. Eur Respir Rev. 2014;23:8–29.

PubMed  Article  Google Scholar 

Eden E, Strange C, Holladay B, Xie L. Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med. 2006;100:1384–91.

PubMed  Article  Google Scholar 

Siri D, Farah H, Hogarth DK. Distinguishing alpha1-antitrypsin deficiency from asthma. Ann Allergy Asthma Immunol. 2013;111:458–64.

CAS  PubMed  Article  Google Scholar 

Eden E, Mitchell D, Mehlman B, Khouli H, Nejat M, Grieco MH, et al. Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency. Am J Respir Crit Care Med. 1997;156:68–74.

CAS  PubMed  Article  Google Scholar 

Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist AS, et al. Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest. 2003;123:765–71.

PubMed  Article  Google Scholar 

Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med. 1994;61:461–7.

CAS  PubMed  Article  Google Scholar 

Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest. 2005;128:1989–94.

CAS  PubMed  Article  Google Scholar 

Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, et al. Does α1-antitrypsin augmentation therapy slow the annual decline in FEV1in patients with severe hereditaryα1-antitrypsin deficiency? Eur Respir J. 1997;10:2260–3.

CAS  PubMed  Article  Google Scholar 

Wencker M, Fuhrmann B, Konietzko N, Banik N. Longitudinal follow-up of patients with α1-protease inhibitor deficiency before and during therapy with IV α1-protease inhibitor. Chest. 2001;119:737–44.

CAS  PubMed  Article  Google Scholar 

Tonelli AR, Rouhani F, Li N, Schreck P, Brantly ML. Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank. Int J Chron Obstruct Pulmon Dis. 2009;4:443–52.

PubMed  PubMed Central  Article  Google Scholar 

Society AT, Society ER. ATS/ERS statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 2003;168.

Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency. Pi Z Acta Med Scand. 1978;204:345–51.

CAS  Article  Google Scholar 

Tobin MJ, Cook PJ, Hutchison DC. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Chest. 1983;77:14–27.

McElvaney NG, Stoller JK, Buist AS, Prakash UB, Brantly ML, Schluchter MD, et al. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest. 1997;111:394–403.

Aiello M, Frizzelli A, Pisi R, Fantin A, Ghirardini M, Marchi L, et al. Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients. J Asthma. 2020;1–8.

Colp C, Pappas J, Moran D, Lieberman J. Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest. 1993;103:812–5.

CAS  PubMed  Article  Google Scholar 

van Veen IH, ten Brinke A, van der Linden AC, Rabe KF, Bel EH. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma. Respir Med. 2006;100:1534–9.

PubMed  Article  Google Scholar 

Montealegre F, Delgado A, Toro A, Vargas W, Chardon D, Bayona M, et al. Alfa 1 antitrypsin and protease levels in Puerto Rican asthmatics: a pilot study. P R Health Sci J. 2006;25:117–25.

PubMed  Google Scholar 

Eden E, Holbrook JT, Brantly ML, Turino GM, Wise RA. Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma–results from the ALA-ACRC low-dose theophylline trial. J Asthma. 2007;44:605–8.

CAS  PubMed  Article  Google Scholar 

Miravitlles M, Vila S, Torrella M, Balcells E, Rodriguez-Frias F, de la Roza C, et al. Influence of deficient alpha1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults. Respir Med. 2002;96:186–92.

CAS  PubMed  Article  Google Scholar 

Suarez-Lorenzo I, de Castro FR, Cruz-Niesvaara D, Herrera-Ramos E, Rodriguez-Gallego C, Carrillo-Diaz T. Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites. Clin Transl Allergy. 2018;8:44.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Vignola AM, Bonanno A, Mirabella A, Riccobono L, Mirabella F, Profita M, et al. Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med. 1998;157:505–11.

CAS  PubMed  Article 

留言 (0)

沒有登入
gif